1nhaler, an Edinburgh, Scotland, UK-based drug delivery device developer, has raised £2M in funding.
The round was led by Archangels with support from Dr Yusuf Hamied, British Business Investments (BBI) and seed investors.
The company intends to use the funds to work with companies around the world, allowing them to bring new and existing drugs to patients.
Led by Lisa McMyn, Founder and CEO, 1nhaler is advancing a breath-activated, single dose, disposable dry powder inhaler that is the size of a credit card. Its patented mechanism for drug delivery allows to transform from its basic 2D flat shape into a 3D inhaler that can deliver a broad variety of inhalable drugs. This device is made from cardboard and completely flat in storage. As a result, it is portable, distributable and recyclable.
FinSMEs
27/11/2023